**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 213696-55-0 |2-Thio-6-hydroxypurine hydrate | 98 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully
investigated.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical
aid if cough or other symptoms appear.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid breathing dust.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 2487-40-3:
CAS# 213696-55-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
The absence of published exposure limits does not
mean that a substance poses no inhalation hazard. If
inhalation exposure is likely or if irritation or
other symptoms are experienced, wear a NIOSH/MSHA or
European Standard EN 149 approved respirator.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: beige to yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 300 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: slightly soluble in water
Specific Gravity/Density:
Molecular Formula: C5H4N4OS.xH2O
Molecular Weight: 168.17
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Not available.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon
dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 2487-40-3: UP0825000
CAS# 213696-55-0 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
6H-Purin-6-one, 1,2,3,7-tetrahydro-2-thioxo-, anhydrous -
Not listed by ACGIH, IARC, or NTP.
2-Thio-6-hydroxypurine hydrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 2487-40-3: No information available.
CAS# 213696-55-0: No information available.
Canada
CAS# 2487-40-3 is listed on Canada's NDSL List.
CAS# 2487-40-3 is not listed on Canada's Ingredient Disclosure List.
CAS# 213696-55-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2487-40-3 is listed on the TSCA inventory.
CAS# 213696-55-0 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 9/02/1997 Revision #3 Date: 4/27/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Sulfamic acid
| 5329-14-6 |
|
3-Chlorocinnamic Acid, Predominantly Trans 99+%
| 1866-38-2 |
|
4-(Bromomethyl)-7-Methoxycoumarin 99%
| 35231-44-8 |
|
2-Hydroxy-3-nitropyridine, 98%
| 6332-56-5 |
|
Sulfanilamide
| 63-74-1 |
|
Sulfanilic acid
| 121-57-3 |
|
Nicotine sulfate, 40% aqueous solution
| 65-30-5 |
|
2-Bromobenzaldehyde, 97%
| 6630-33-7 |
|
Bicyclo (3.2.1)Octan-2-One, 90-95%(GC)
| 5019-82-9 |
|
Benzo??b??naphtho??2,3-d??thiophene, 99.5+%
| 243-46-9 |
|
Triethyl Orthoacetate, 99% (GC)
| 78-39-7 |
|
5-Sulfosalicylic acid dihydrate
| 97-05-2 |
|
4-Benzoyloxy-2-Azetidinone, 99%
| 28562-58-5 |
|
Sulfur (Precipitated and Sublimed)
| 7704-34-9 |
|
N-Methyl-Beta-Alaninenitrile, 98%
| 693-02-7 |
|
Trimethyl Orthovalerate
| 13820-09-2 |
|
Ethyl diethoxyphosphinylformate, 98%
| 1474-78-8 |
|
S-Methyl-L-Cysteine, 99+%
| 1187-84-4 |
|
N-Benzoyl-4-Piperidone, 97%
| 24686-78-0 |
|
Succinimide, 99%
| 123-56-8 |
|
Sulfuric acid 90-98%
| 7664-93-9 |
|
Sulfurous Acid
| 7782-99-2 |
|
Silver trifluoromethanesulfonate, 99+%
| 2923-28-6 |
|
Rhodanine-n-acetic acid, 98%
| 5718-83-2 |
|
Tannic Acid
| 1401-55-4 |
|
Diphenic Anhydride, 98%
| 6050-13-1 |
|
4-(Dimethylamino)butyric Acid Hydrochloride, 98%
| 69954-66-1 |
|
(4S,5S)-4,5-Di(aminomethyl)-2,2-dimethyldioxolane, 99+%
| 119322-88-2 |
|
4-Acryloylamidobenzo-18-Crown-6, 98%
| 0-00-1 |
|
2-Thio-6-hydroxypurine hydrate, 98%
| 2487-40-3 |
|
3-Methyl-4-nitrobenzoic acid, 99%
| 3113-71-1 |
|
L-(+)-Tartaric acid
| 87-69-4 |
|
3-Methyl-2-pyrazolin-5-one, 99% (titr.)
| 108-26-9 |
|
2-Nitronaphthalene, tech., 85%
| 581-89-5 |
|
2,6-Dibromopyridine, 98%
| 626-05-1 |
|
5-Methylfurfural, 98+%
| 620-02-0 |
|
Ammonium orthoarsenate trihydrate, 99.999%
| 13477-86-6 |
|
n-Benzylglycine ethyl ester hydrochloride, 98%
| |
|
N-Alpha-Acetyl-L-Lysine-N-Methylamide Monohydrate, 99+%, (TLC)
| 81013-00-5 |
|
(+)-Dimethyl L-Tartrate, 99%
| 608-68-4 |
|
2,5-Dibromotoluene, 99%
| 615-59-8 |
|
2-Aminoperimidine, Hydrobromide Sesquihydrate, 98%
| 40835-96-9 |
|
Nucleic Acid (Pract), 90% (UV-VIS)
| 9008-72-4 |
|
Ethyl 3-Endo-Aminobicyclo[2.2.1]Hept-5-ene -2-Endo-Carboxylate
| 95630-74-3 |
|
Cyclopentanemethanol, 96%
| 3637-61-4 |
|
Tetrahexylammonium Bromide, 99% (Titr.)
| 4328-13-6 |
|
1-(4-Chlorophenyl)-1-cyclohexanecarbonitrile
| |
|
Potassium deuteroxide, 40 wt% solution in d2o, 98+ atom % d
| 24572-01-8 |
|
1-(2-Methoxyphenyl)piperazine, 98+% (GC)
| 35386-24-4 |
|
4-Carboxybenzo-15-Crown-5, 99+%
| 0-00-1 |
|
|